WHO considering pandemic rethink

12 May 2009

The World Health Organization is considering a re-think of its global pandemic rating system, following criticism of the current swine  influenza response. The six-point scale shifted from a phase 3 "little  or no human-to-human transmission" to phase 5, a regional pandemic. By  its own definition the maximum level 6, community-wide transmission in  at least two WHO regions, could have been reached with over 2,000  infections in over 20 countries.

The problem for the alert system has been that the severity of the type  (A) H1N1 virus has not been as great as predicted. As a result, the same  pandemic alert level is used as would apply if a virulent flu pandemic  were to kill millions of people, as happened with the 1918-20, 1957-58  and 1968-69 pandemics.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight